Table 4 Unadjusted regression of barriers and facilitators to obtaining a DATA-2000 waiver

Barriers

 Reimbursement concerns

0.44

0.3

0.09

2.07

 Prior authorization

0.64

0.55

0.15

2.8

 No behavioral health counseling

1.65

0.4

0.51

5.28

 No addiction specialist

0.57

0.3

0.2

1.65

 No psychiatrist

0.75

0.61

0.25

2.28

 No confidence in management

0.43

0.19

0.12

1.53

 Lack of patient demand

1.43

0.58

0.41

4.98

 Too many requests

2.61

0.38

0.3

22.52

 Diversion/misuse

0.42

0.18

0.12

1.49

 Prefer non-buprenorphine treatment

0.26

0.12

0.05

1.43

 Time constraints

0.94

0.91

0.28

3.09

 Institutional resistance

1.34

0.73

0.26

6.94

 DEA intrusion

0.21

0.02

0.06

0.78

Facilitators

 Mentorship

0.89

0.83

0.3

2.59

 Online education

0.36

0.06

0.12

1.06

 In-person education

0.49

0.21

0.16

1.48

 Increased reimbursement

0.7

0.51

0.24

2.02

 Easy referral to behavioral health

2.24

0.15

0.75

6.74

 Direct access to addiction specialist and counseling

1.3

0.67

0.39

4.33

 Improved guidelines for OUD treatment

1.73

0.33

0.58

5.21

 Institutional support

1.11

0.85

0.38

3.26

 Increased demand

1.89

0.26

0.62

5.80

 Nothing

0.95

0.95

0.22

4.05